Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion type Assertion NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_head.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion description "[We then projected the effectiveness of tissue plasminogen activator (TPA) on disability as estimated with the aid of the odds ratio from the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA Stroke Trial onto our unselected sample to evaluate clinical efficiency of treatment as a function of arrival time and of hypothetical effects of educational efforts to reduce it.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion evidence source_evidence_curated NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion SIO_000772 9056608 NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion wasDerivedFrom ctd_human-20150221 NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.
- NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_assertion wasGeneratedBy ECO_0000218 NP26050.RAt-0vd9dD-3hMkgYrXJ5D9pVpxk200WL_pdQ7_e_Csqg130_provenance.